Keio Center for Clinical Research is Research is founded to clinical research and human resources.

 Massachusetts General Hospital (MGH), one of the leading teaching hospitals affiliated with the Harvard University, has its own Academic Research Organisation, the Clinical Trial Network Institute (CTNI, executive director: Professor Maurizio Fava), to lead multinational multisite clinical trials of highest quality.  Following Prof. Fava’s direct proposal to Prof. Yuji Sato (director, Keio Centre for Clinical Research), a clinical trial service agreement between MGH-CTNI and Keio University School of Medicine (Dean: Professor Makoto Suematsu) was signed off on 11^th January 2011, in order to mutually coordinate a global clinical trial in psychiatry, so that high-level clinical judgement can be ensured to enrol most ideal patients to enable robust investigation of a new test drug. MGH-CTNI and Keio CCR has already started collaborative efforts, through transpacific to and fro and regular teleconferences, to prepare for smooth initiation of the trial.

 Under this collaboration, final clinical judgement for enrolling patients is given by MGH-CTNI in the US and EU, while that in Japan is to be given by the psychiatrists at the Department of Psychiatry at Keio and at the Clinical Trial Division, National Centre of Neurology and Psychiatry, through coordination and management by Keio CCR.

 Further collaboration between these two AROs to mutually provide state of the art supervision and coordination of global trials is expected.